Two Sigma Securities »

Context Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $33k 13k 2.62
2022-12-31 $13k 19k 0.65
2022-09-30 $28k 25k 1.13

More positions owned by Two Sigma Securities

Ishares Tr Core Us Aggbd Et (AGG)
Amazon (AMZN)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Tesla Motors (TSLA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Tips Bd Etf (TIP)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr Gold Tr Gold Shs (GLD)
Norfolk Southern (NSC)

View all positions for Two Sigma Securities

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Blue Owl Capital Holdings
Nextech Invest
Deep Track Capital
Soleus Capital Management
Octagon Capital Advisors
Avidity Partners Management
Franklin Resources
Vanguard Group
Vanguard Capital Management
TCG Crossover Management
Marshall Wace
Dr. Jeffrey R. Jay, M.D.
Millennium Management
Sio Capital Management

View all funds holding Context Therapeutics